COMMUNIQUÉS West-GlobeNewswire

OncoMed Announces Appointment of John Lewicki, PhD, as President, Chief Executive Officer and a member of the Board of Directors
19/03/2018
REDWOOD CITY, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED ), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]
United Health Products Forms Medical Advisory Board
19/03/2018
HENDERSON, Nev., March 19, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, is [...]
Progenics Pharmaceuticals Announces Presentation of AZEDRA® (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society (ENDO) Annual Meeting
19/03/2018
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and other products for targeting and treating cancer, announced that [...]
Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full Year 2017 Financial Results
19/03/2018
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”) (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]
Histogenics Corporation to Present at Needham & Company’s 17th Annual Healthcare Conference
19/03/2018
WALTHAM, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]
American Gene Technologies Gains Additional Immuno-Oncology Patent
19/03/2018
ROCKVILLE, Md., March 19, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced receipt of a second immuno-oncology patent on the [...]
Cellectar Biosciences Granted Orphan Drug Designation for CLR 131 to Treat Neuroblastoma
19/03/2018
MADISON, Wis., March 19, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]
Sorrento Therapeutics Welcomes Jiong Shao as Chief Financial Officer and Reaffirms Intent to Seek Nasdaq/HKSE Dual Listing in 2018
19/03/2018
SAN DIEGO, March 19, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento") announced today that it appointed Mr Jiong Shao as Executive Vice President and Chief Financial Officer. Jiong is an [...]
Corium to Present at the 17th Annual Needham Healthcare Conference
19/03/2018
MENLO PARK, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]
Collegium Announces the Appointment of Shirley Kuhlmann as General Counsel
19/03/2018
CANTON, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced the appointment of Shirley Kuhlmann to the newly created position of Executive Vice President and General [...]
resTORbio Announces Formation of Clinical Advisory Board
19/03/2018
Esteemed Experts Engaged as Company Advances Clinical Development Program Phase 2b Data for Lead Program Expected in the Second Half of 2018 BOSTON, March 19, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ) [...]
MannKind Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference
19/03/2018
WESTLAKE VILLAGE, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ) focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]
Catalyst Biosciences to Present at The Needham and Company 17th Annual Healthcare Conference
19/03/2018
SOUTH SAN FRANCISCO, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Fibrocell Reports 2017 Financial Results and Recent Highlights
19/03/2018
- Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT - EXTON, Pa., March 19, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational [...]
Cellectar Biosciences to Host 2017 Financial Results and Business Update Conference Call on March 22, 2018
19/03/2018
MADISON, Wis., March 19, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]
Mersana Strengthens Board of Directors Leadership with Appointment of Willard H. Dere, M.D., Professor at the University of Utah and Retired Chief Medical Officer of Amgen
19/03/2018
CAMBRIDGE, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Denali Therapeutics Announces First-In-Human Dosing Of Its RIPK1 Inhibitor Clinical Program And The Appointment Of Peter Klein To Board Of Directors; Reports Fourth Quarter And Full Year 2017 Financial Results And Business Highlights
19/03/2018
SOUTH SAN FRANCISCO, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases [...]
INSYS Therapeutics Reiterates Commitment to Compliant and Ethical Business Practices and Advancing Innovative Product Pipeline
19/03/2018
PHOENIX, March 19, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released [...]
US Food and Drug Administration (FDA) provides communication to Spectral
19/03/2018
TORONTO, March 19, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT ), a Phase III company developing the first targeted treatment for patients with septic shock today announced that the FDA has determined that [...]

Pages